ZBH EBITDA Growth
Zimmer Biomet · EBITDA Growth
ZBH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.72%period ending
ZBH TTM EBITDA YoY % (-6.63% → 2.72%)
Year-over-year change
High-resolution chart · PNG
ZBH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 2.7161% | |
| 0.7796% | |
| -1.4883% | |
| 7.4851% | |
| 3.9709% | |
| 6.4093% | |
| 1.3828% | |
| 20.2065% | |
| 22.9231% | |
| 28.029% | |
| 48.5382% | |
| 24.7289% | |
| 18.6392% | |
| 12.495% | |
| -7.9732% | |
| -24.7565% | |
| -26.9141% | |
| -10.4162% | |
| 67.3915% | |
| 86.4695% | |
| 110.3258% | |
| 24.6757% | |
| -54.6334% | |
| 5.3385% | |
| -1.1143% | |
| 23.1885% | |
| 102.4612% | |
| -45.191% | |
| -45.6358% | |
| -39.6397% | |
| -43.0451% | |
| -9.2558% | |
| -9.8585% | |
| -6.1687% | |
| 3.228% | |
| 3.935% | |
| 11.2738% | |
| 47.5292% | |
| 55.9451% | |
| 103.8417% | |
| 96.2706% | |
| -1.437% | |
| -16.8207% | |
| -36.4946% | |
| -36.9256% | |
| -7.188% | |
| -1.738% | |
| 15.1501% | |
| 10.4365% | |
| 0.4938% | |
| -1.15% | |
| -6.7238% | |
| -6.2181% | |
| 3.9372% | |
| 5.3483% | |
| -9.1082% | |
| -7.7004% | |
| -9.0309% | |
| -9.4878% | |
| 3.8741% | |
| 7.3243% | |
| 0.7865% | |
| 1.5757% | |
| 3.2201% | |
| 2.2745% | |
| 6.3103% | |
| 2.7065% | |
| -5.0809% | |
| -0.8819% | |
| -0.0643% | |
| 3.6737% | |
| 12.0421% | |
| -3.9549% | |
| -1.1926% | |
| 1.0302% | |
| 0.4873% | |
| 11.1702% | |
| 7.9613% | |
| 5.5037% | |
| 6.9521% | |
| 9.3771% | |
| 17.3641% | |
| 26.4918% | |
| 36.0127% | |
| 10.5744% | |
| 11.8668% | |
| 12.1414% | |
| 9.3422% | |
| 109.2754% | |
| 110.9198% | |
| 114.5847% | |
| 117.4125% | |
| 54.0717% | |
| 56.539% | |
| 56.8642% | |
| 41.1786% | |
| 17.6245% | |
| 4.8114% | |
| -6.6323% |